Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used due to their profound efficacy in glycemic control and weight management. Within real-world contexts, the manifestation of certain psychiatric adverse events (AEs) has been observed, which is potentially linked to the ad...

Full description

Bibliographic Details
Main Authors: Wei Chen, Peishan Cai, Wenbin Zou, Zhiwen Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Endocrinology
Subjects:
glucagon-like peptide-1 receptor agonists
psychiatric adverse events
disproportionality analyses
FAERS database
pharmacovigilance study
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1330936/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1330936/full

Similar Items